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Metabolic syndrome in postmenopausal women: higher prevalence in the
Northeastern Region of Brazil than in other Latin American countries
and the influence of obesity and socioeconomic factors
We read with great interest the recent manuscript,
by the Collaborative Group for Research of the
Climacteric in Latin America, on the prevalence of
metabolic syndrome (METS) and its components
in postmenopausal Latin American women1. The
authors analyzed the prevalence of METS accord-
ing to the National Cholesterol Education Pro-
gram Adult Treatment Panel III (NCEP)2 in a total
of 3965 postmenopausal women, aged 45–64
years, and observed a high prevalence of METS,
ranging from 28.1% in women aged 40–44 years
to 42.9% in those aged 60–64 years.
This is an extremely relevant topic in the current
clinical management of climacteric, since coronary
heart disease (CHD) is the leading cause of
morbidity and mortality in postmenopausal women
throughout the world and it has been estimated that
a woman dies from heart disease every minute3.
After menopause, the risk of developing CHD
increases significantly and METS emerges as a
constellation of risk factors including hypertension,
increase in abdominal fat (adiposity), abnormal
lipoprotein levels, and insulin resistance, all of
which appear to occur with estrogen deficiency4,5.
In the cited article1, only Latin American
women of Hispanic origin were assessed and no
data on the Brazilian population were included.
Brazil, a country of continental dimensions, has
about 15 million postmenopausal women and
widely diverse regions in terms of dietary habits
and human development indicators6. In Brazil, the
prevalence of obesity, hypertension, diabetes and
other cardiovascular risk factors has increased in
all regions, regardless of socioeconomic level and
cultural context7.
Given that no information is available on the
prevalence of METS in Brazilian postmenopausal
women, we would like to report data from a study
aimed at assessing the prevalence of metabolic
syndrome in very low-income postmenopausal
women living in Rio Grande do Norte, a tropical
state with a human development index of 0.668
located in the Northeastern region of Brazil.
Our study consisted of 127 postmenopausal
women (mean age 53.9+4.6 years), of which
53.5% were illiterate and 70.1% were living below
the poverty line (per capita income5US $70.00).
The prevalence of METS in the entire sample was
48.0% and we observed an ascending rate when
the 45–49-year-old group was compared to the
older age groups (Table 1). We also found that a
considerable proportion (29.9%) of these women
had two criteria and 20.5% had one criterion for
METS. Only two women had no METS factor. A
very interesting association was observed between
METS and family income, since METS was more
frequent in women with income 5120 dollars per
month when compared to the higher income group
(62.5 and 50.5%, respectively).
The most prevalent isolated METS abnormality
was high density lipoprotein cholesterol below
50 mg/dl, present in 96.1%, followed by hyper-
tension in 51.2%, increased waist circumference
in 46.5%, increased serum triglycerides in 40.9%,
and high fasting glucose concentrations
(110 mg/dl) in 18.1%. We also found that the
occurrence of hypertension and increased waist
circumference was significantly associated with
the presence of obesity. The prevalence of other
METS components was independent of body mass
index, hormone therapy, physical activity level,
family income and schooling.
When fasting plasma glucose (FPG) levels were
analyzed according to recent recommendations
of the Expert Committee of the American
Diabetes Association8, we found that 38
(29.9%) women had impaired fasting glucose
(FPG 100–125 mg/dl), and 10 (7.9%) were
classified as diabetic (FPG 126 mg/dl). Consid-
ering the criteria for METS recommended by the
International Diabetes Federation9 (waist circum-
ference 80 cm and FPG 100 mg/dl), the pre-
valence of METS in Brazilian postmenopausal
women was 61.4%. All these rates are higher
than results reported for women from other
Latin America countries by the Collaborative
Group for Research of the Climacteric in Latin
America1. Thus, Brazilian postmenopausal wo-
men constitute a population with increased risk
for cardiovascular disease.
Our results corroborate the cited study1
in that the analysis of cardiovascular risk in
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postmenopausal women must take into account
data from studies conducted in different popula-
tions. In this context, it is possible to consider the
potential influence of obesity and other important
aspects such as genetic background, dietary habits
and lifestyle characteristics affecting the preva-
lence of METS in climacteric women.
It is relevant to point out that the high
prevalence of METS in Brazilian postmenopausal
women represents enormous cardiovascular risk,
with serious implications for the public health
system. Thus, clinicians and family doctors should
screen for parameters that define METS as part of
their management of climacteric women.
In conclusion, the prevalence of METS in very
low-income postmenopausal women from the
Northeastern Region of Brazil is higher than that
reported for Latin America as a whole1. This could
be due to the increased prevalence of obesity, genetic
factors, inadequate lifestyle and dietary habits, and
environmental factors such as stress related to the
precarious conditions of life and of health. The
results emphasize the need for optimizing preven-
tive, diagnostic and care strategies for cardiovascu-
lar disease in the postmenopausal years.
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Table 1 Number of NCEP* metabolic syndrome criteria in Brazilian postmenopausal women (n¼ 127). The
shaded area represents the prevalence of metabolic syndrome (presence of three or more risk factors)
Age group (years)
NCEP criteria n (%)
Total0 1 2 3 4 5
45–49 – 8 (38.1) 8 (38.1) 3 (14.3) 1 (4.8) 1 (4.8) 21 (100.0)
50–54 2 (3.7) 12 (22.2) 10 (18.5) 16 (29.6) 11 (20.4) 3 (5.6) 54 (100.0)
55–59 – 5 (13.2) 15 (39.5) 12 (31.6) 4 (10.5) 2 (5.3) 38 (100.0)
60–64 – 1 (7.1) 5 (35.7) 2 (14.3) 5 (35.7) 1 (7.1) 14 (100.0)
Total 2 (1.6) 26 (20.5) 36 (29.9) 33 (26.0) 21 (16.5) 7 (5.5) 127 (100.0)
*Third Report of the National Cholesterol Education Program (NCEP), 20012
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